🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 25 of 151

  1. Bempedoic acid 180mg

    Esperion Therapeutics

    Hypercholesterolemia

    phase 2 small molecule completed

    2 trials

  2. Bempedoic acid, bempedoic acid

    Esperion Therapeutics

    Heterozygous familial hypercholesterolemia, Heterozygous Familial Hypercholesterolemia

    phase 2 small molecule active

    1 trial

  3. Bempegaldesleukin

    Nektar Therapeutics UK Limited

    Urinary Bladder Neoplasm

    phase 2 mab completed

    1 trial

  4. Bendafolin 10 mg/ml Injektionslösung, Benda-5 FU 50 mg/ml Injektionslösung, Xtandi - 40 mg film-coated tablets, Zirabev 25 mg/ml concentrate for solution for infusion, BENDAFOLIN 10 mg/ml Injektionslösung, 5-FLUOROURACIL–EBEWE, 50 MG/ML, ROZTWÓR DO WSTRZYKIWAN I INFUZJI, 5-Флуороурацил Ебеве 50 mg/ml концентрат за инжекционен и инфузионен разтвор., Calciumfolinat Kabi 10 mg/ml Injektions-/Infusionslösung, 5-FU medac 50 mg/ml, Injektionslösung, Zirabev 25 mg/ml concentrate for solution for infusion

    GlaxoSmithKline

    Neoplasms

    phase 2 small molecule active

    1 trial

  5. Bendamustine

    Teva Pharma GmbH

    Leukemia

    phase 2 small molecule completed

    1 trial

  6. Bendamustine

    Adaptive Biotechnologies Corp

    Lymphoma

    phase 2 small molecule active

    1 trial

  7. Bendamustine

    Teva Pharma GmbH

    Mantle Cell Lymphoma

    phase 2 small molecule completed

    1 trial

  8. Bendamustine hydrochloride

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma (NHL)

    phase 2 small molecule completed

    1 trial

  9. Bendatax 6 mg/ ml, TAGRISSO 80 mg film-coated tablets, CISPLATIN, CARBOPLATIN, PEMETREXED, Cisplatin 1mg/ml Concentrate for Solution for Infusion, TAGRISSO 40 mg film-coated tablets, Armisarte 25 mg/ml concentrate for solution for infusion, Carboplatin 10 mg/ml concentrate for solution for infusion, PACLITAXEL

    AstraZeneca AB

    Unresectable Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  10. Benlysta 200 mg solution for injection in pre-filled pen., Benlysta 200 mg solution for injection in pre-filled pen., Benlysta 200 mg solution for injection in pre-filled pen.

    GlaxoSmithKline

    Systemic Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  11. Benlysta 200 mg solution for injection in pre-filled syringe., Placebo of belimumab

    Pari Pharma GmbH

    Cryoglobulinemia vasculitis

    phase 2 small molecule active

    1 trial

  12. Benmelstobart

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  13. Benznidazole

    BRIGHT MINDS BIOSCIENCES INC.

    Trypanosoma Cruzi Infection

    phase 2 small molecule completed

    1 trial

  14. Bepranemab, Placebo matching and without active substance, Neuraceq 300 MBq/mL solution for injection, (18F) GTP1

    Lacuna Pharma Pty Ltd

    Alzheimer’s Disease

    phase 2 small molecule active

    1 trial

  15. Berubicin

    CNS Pharmaceuticals

    Glioblastoma Multiforme, Adult

    phase 2 small molecule active

    1 trial

  16. Berubicin hydrochloride

    Rani Therapeutics Holdings

    central nervous system (CNS) lymphomas

    phase 2 small molecule active

    1 trial

  17. Berubicin hydrochloride, Cecenu® 40 mg Kapsel

    CNS Pharmaceuticals

    Glioblastoma multiforme (GBM)

    phase 2 small molecule active

    1 trial

  18. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Colorectal Neoplasms

    phase 2 small molecule terminated

    1 trial

  19. Bevacizumab

    ONCOLYTICS BIOTECH INC

    Ras-mutated Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial

  20. Bevacizumab

    The First People's Hospital of Lianyungang

    Lung, Carcinoma

    phase 2 small molecule active

    1 trial

  21. Bevacizumab

    United Therapeutics Europe Ltd

    Recurrent Glioblastoma

    phase 2 mab active

    1 trial

  22. Bevacizumab

    United Therapeutics Europe Ltd

    Colorectal Adenocarcinoma

    phase 2 mab completed

    1 trial

  23. Bevacizumab

    United Therapeutics Europe Ltd

    Metastatic Melanoma

    phase 2 mab completed

    1 trial

  24. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  25. Bevacizumab

    The First People's Hospital of Lianyungang

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  26. Bevacizumab

    The First People's Hospital of Lianyungang

    Malignant Pleural Effusion

    phase 2 small molecule active

    1 trial

  27. Bevacizumab Biosimilar IBI305

    The First People's Hospital of Lianyungang

    Post-orthotopic Liver Transplantation

    phase 2 small molecule active

    1 trial

  28. Bevacizumab combined with Oxaliplatin and TAS-102

    The First People's Hospital of Lianyungang

    Advanced Colorectal Cancer

    phase 2 small molecule active

    1 trial

  29. Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  30. Bevacizumab/Irinotecan

    Solid Biosciences

    Glioblastoma

    phase 2 small molecule completed

    1 trial

  31. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Sarcoma, Kaposi

    phase 2 small molecule completed

    1 trial

  32. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  33. Bexarotene (targretin)

    LIGAND PHARMACEUTICALS INC

    Carcinoma, Non-small-cell Lung

    phase 2 small molecule terminated

    1 trial

  34. Bexarotene 1% gel

    LIGAND PHARMACEUTICALS INC

    Parapsoriasis

    phase 2 small molecule terminated

    1 trial

  35. Bexarotene/NBUVB vs placebo NBUVB

    LIGAND PHARMACEUTICALS INC

    Psoriasis

    phase 2 small molecule completed

    1 trial

  36. Bexmarilimab

    Lacuna Pharma Pty Ltd

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  37. Bezuclastinib Tablets (Formulation A)

    Cogent Biosciences

    SSM

    phase 2 small molecule active

    1 trial

  38. Bezuclastinib in combination with sunitinib

    Cogent Biosciences

    Gastrointestinal Stromal Tumors

    phase 2 small molecule active

    1 trial

  39. Bicalutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Neoplasms

    phase 2 small molecule active

    1 trial

  40. Bicarbonate de sodium

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Disease

    phase 2 small molecule completed

    1 trial

  41. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Diabetic Peripheral Neuropathy

    phase 2 small molecule active

    1 trial

  42. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Chronic Peripheral Neuropathy Pain in Diabetics

    phase 2 small molecule terminated

    1 trial

  43. BinD19

    The First People's Hospital of Lianyungang

    Relapsed B-cell Acute Lymphoblastic Leukemia

    phase 2 mab active

    1 trial

  44. Binimetinib

    United Therapeutics Europe Ltd

    Metastatic Colorectal Carcinoma

    phase 2 small molecule completed

    1 trial

  45. Binimetinib

    United Therapeutics Europe Ltd

    Locally Advanced Pancreatic Carcinoma

    phase 2 small molecule terminated

    1 trial

  46. Bioengineered Artificial Mesenchimal Sheet (BAMS)

    Lxo Ireland Designated Activity Company

    Venous Ulcer

    phase 2 mab active

    1 trial

  47. Bion 1301/FUB523

    Novartis Pharmaceuticals

    IgA nephropathy

    phase 2 small molecule active

    1 trial

  48. Bispecific antibody-based combined with CAR-T cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    B-cell Non-Hodgkin Lymphoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.